跳出心脏范畴思考：肥厚型心肌病合并心房颤动的治疗 - Suppr

Suppr

超能文献

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy.

作者信息

Rowin Ethan J, Sridharan Aadhavi

机构信息

Division of Cardiology HCM Institute Tufts Medical Center Boston MA.

出版信息

J Am Heart Assoc. 2020 Apr 21;9(8):e016260. doi: 10.1161/JAHA.120.016260. Epub 2020 Apr 16.

DOI:10.1161/JAHA.120.016260

PMID:32297545

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7428532/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167a/7428532/f7c5b59191b0/JAH3-9-e016260-g001.jpg

相似文献

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy.跳出心脏范畴思考：肥厚型心肌病合并心房颤动的治疗

J Am Heart Assoc. 2020 Apr 21;9(8):e016260. doi: 10.1161/JAHA.120.016260. Epub 2020 Apr 16.

Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy.缺乏可靠的临床预测因子来识别肥厚型心肌病患者中的阻塞性睡眠呼吸暂停。

Clinics (Sao Paulo). 2013 Jul;68(7):992-6. doi: 10.6061/clinics/2013(07)17.

Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.阻塞性睡眠呼吸暂停和肥厚型心肌病：一种常见且潜在有害的组合。

Sleep Med Rev. 2013 Jun;17(3):201-6. doi: 10.1016/j.smrv.2012.06.006. Epub 2012 Oct 6.

Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find, and Treat.梗阻性肥厚型心肌病中的心房颤动：筛查、发现与治疗

Ann Thorac Surg. 2022 Jun;113(6):1925. doi: 10.1016/j.athoracsur.2021.09.075. Epub 2021 Nov 13.

Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病患者心房颤动的管理

Circulation. 2016 May 10;133(19):1901-5. doi: 10.1161/CIRCULATIONAHA.115.015085.

Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report.肥厚型心肌病伴心室中部梗阻及脾梗死合并阵发性心房颤动：一例报告

J Cardiol. 1999 Nov;34(5):273-7.

Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?心房颤动与肥厚型心肌病：该对谁进行抗凝治疗？

Clin Res Cardiol. 2015 Oct;104(10):799-802. doi: 10.1007/s00392-015-0876-6. Epub 2015 Jul 2.

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病患者行心肌切除术同期行房颤消融术。

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1536-1542.e2. doi: 10.1016/j.jtcvs.2017.08.063. Epub 2017 Sep 1.

Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten.接受马伐卡坦治疗的梗阻性肥厚型心肌病患者中新发房颤的发生率。

Heart Rhythm. 2024 Oct;21(10):2065-2067. doi: 10.1016/j.hrthm.2024.04.055. Epub 2024 Apr 15.

Obstructive sleep apnea a respiratory syndrome with protean cardiovascular manifestations.阻塞性睡眠呼吸暂停是一种具有多种心血管表现的呼吸综合征。

J Am Coll Cardiol. 2009 Nov 3;54(19):1810-2. doi: 10.1016/j.jacc.2009.06.039.

引用本文的文献

Association between the Albumin-to-Globulin Ratio and Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者白蛋白与球蛋白比值和心房颤动之间的关联

Rev Cardiovasc Med. 2024 Mar 7;25(3):96. doi: 10.31083/j.rcm2503096. eCollection 2024 Mar.

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy.心房颤动和肥厚型心肌病患者的外科及经导管左心耳封堵术

Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad101.

PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.导致家族性心房颤动的 PRRX1 功能丧失突变。

J Am Heart Assoc. 2021 Dec 7;10(23):e023517. doi: 10.1161/JAHA.121.023517. Epub 2021 Nov 30.

Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.合并症对肥厚型心肌病中心律失常和心源性猝死的影响。

J Cardiovasc Electrophysiol. 2022 Jan;33(1):20-29. doi: 10.1111/jce.15304. Epub 2021 Dec 8.

本文引用的文献

Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.阻塞性睡眠呼吸暂停严重程度指标——呼吸暂停低通气指数对肥厚型心肌病合并心房颤动患者的影响。

J Am Heart Assoc. 2020 Apr 21;9(8):e015013. doi: 10.1161/JAHA.119.015013. Epub 2020 Apr 16.

Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.联合 Cox-Maze IV 与室间隔心肌切除术治疗梗阻性肥厚型心肌病伴心房颤动的疗效。

Am J Cardiol. 2020 Jan 1;125(1):120-126. doi: 10.1016/j.amjcard.2019.09.029. Epub 2019 Oct 11.

Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.肥胖与肥厚型心肌病不良长期结局的相关性。

JAMA Cardiol. 2020 Jan 1;5(1):65-72. doi: 10.1001/jamacardio.2019.4268.

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.美国心脏病学会/美国心脏协会优化的肥厚型心肌病高危患者心源性猝死预防策略。

JAMA Cardiol. 2019 Jul 1;4(7):644-657. doi: 10.1001/jamacardio.2019.1391.

Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.心脏磁共振成像显示，肥厚型心肌病伴阵发性心房颤动患者左心房纤维化负担重。

JACC Clin Electrophysiol. 2019 Mar;5(3):364-375. doi: 10.1016/j.jacep.2018.10.016. Epub 2018 Dec 26.

Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理

N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.

Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy.先进疗法对改善肥厚型心肌病患者心脏移植生存率的影响。

Am J Cardiol. 2018 Apr 15;121(8):986-996. doi: 10.1016/j.amjcard.2017.12.044. Epub 2018 Jan 31.

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中心房颤动的临床特征和后果。

Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.

Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation.肥厚型心肌病患者的左心房大小与功能及新发心房颤动风险

Circ Arrhythm Electrophysiol. 2017 Feb;10(2). doi: 10.1161/CIRCEP.116.004052.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.肥厚型心肌病中心房颤动的预测因素

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验